Time trade-off health state utility values for depression: a systematic review and meta-analysis
-
Published:2022-09-30
Issue:4
Volume:32
Page:923-937
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Balázs Péter GyörgyORCID, Erdősi DalmaORCID, Zemplényi AntalORCID, Brodszky ValentinORCID
Abstract
Abstract
Purpose
This study aims to systematically review the literature on health utility in depression generated by time trade-off (TTO) method and to compare health state vignettes.
Methods
Systematic literature search was conducted following PRISMA guideline in 2020 November (updated in 2022 March) in Pubmed, Web of Science, PsycInfo, and Cochrane Database of Systematic Reviews. Random effect meta-analysis was conducted to pool vignette-based utility values of mild, moderate, and severe depression and to compare the preferences of depressed and nondepressed population.
Results
Overall, 264 records were found, 143 screened by title and abstract after removing duplicates, 18 assessed full text, and 14 original publications included. Majority of the studies (n = 9) used conventional TTO method, and most of the studies (n = 8) applied 10-year timeframe. Eight studies evaluated self-experienced health (own-current depression). Six studies assessed vignette-based health states of remitted, mild, moderate, and severe depression, half of them applied McSad measure based health description. Altogether, 61 different utility values have been cataloged, mean utility of self-experienced depression states (n = 33) ranged between 0.89 (current-own depression) and 0.24 (worst experienced depression). Pooled utility estimates for vignette-based mild, moderate, and severe depression was 0.75, 0.66 and 0.50, respectively. Meta-regression showed that severe depression (β = −0.16) and depressed sample populations (β = −0.13) significantly decrease vignette-based utility scores.
Conclusion
Our review revealed extent heterogeneity both in TTO methodology and health state vignette development. Patient’s perception of depression health states was worse than healthy respondents.
Funder
Ministry of Innovation and Technology in Hungary Corvinus University of Budapest
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference71 articles.
1. James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., & Abdelalim, A. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7 2. Bodden, D. H. M., Stikkelbroek, Y., & Dirksen, C. D. (2018). Societal burden of adolescent depression, an overview and cost-of-illness study. Journal of Affective Disorders, 241, 256–262. https://doi.org/10.1016/j.jad.2018.06.015 3. Abdin, E., Chong, S. A., Seow, E., Peh, C. X., Tan, J. H., Liu, J., Hui, S. F. S., Chua, B. Y., Sim, K., Verma, S., Vaingankar, J. A., & Subramaniam, M. (2019). A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore. Psychiatry Research, 274, 400–408. https://doi.org/10.1016/j.psychres.2019.02.077 4. Rowen, D., Azzabi Zouraq, I., Chevrou-Severac, H., & van Hout, B. (2017). International regulations and recommendations for utility data for health technology assessment. PharmacoEconomics, 35(1), 11–19. https://doi.org/10.1007/s40273-017-0544-y 5. Cuijpers, P. (2018). The challenges of improving treatments for depression. JAMA, 320(24), 2529–2530. https://doi.org/10.1001/jama.2018.17824
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|